p63 and p73 show a high degree of structural homology to p53 and are members of a family of transcriptional factors that can activate transcription of p53-responsive genes. p53 is mutated in more than 50% of human cancers, whereas p63 and p73 are rarely mutated. Studies of knockout mice also revealed an unexpected functional diversity among the p53 family. To determine how p63 and p73 are involved in tumorigenesis and normal development, we used cDNA microarray to examine 9216 genes in human colorectal cancer cells. We discovered that the expression of pigment epitheliumderived factor (PEDF) was specifically induced by either p63 or p73, but not by p53. We also report here that the PEDF gene contains a response element specific for p63 and p73 in its promoter region and is a direct target of p63 and p73. Collectively, p63 and p73 may be involved in cell fate by inducing PEDF expression.
The p53 tumor suppressor is the most frequent target gene for genetic alterations in human cancers (Hainaut et al., 1997; Hollstein et al., 1997) . p53 protein is stabilized in response to environmental stimuli such as DNA damage, hypoxia, viral infection or oncogene activation, resulting in transactivation of a specific set of target genes. These targets are involved in cell-cycle arrest, apoptosis, DNA replication, repair, proliferation, inhibition of angiogenesis and cellular stress response (El-Deiry, 1998; Tokino and Nakamura, 2000; Vogelstein et al., 2000) . The recently discovered p53 family members p63 and p73 have very significant homology to p53 in both amino-acid sequence and molecular structure (see reviews, Melino et al., 2002 Melino et al., , 2003 Yang et al., 2002; van Bokhoven and Mckeon, 2002) . Both p63 and p73 can also regulate some genes by binding p53 response elements, suggesting that the p53 family members have a similar function as p53 itself. In fact, p53 and p53 family members share some of the same target genes and p53 family members have a potential for functional overlap with p53. On the other hand, major differences between p53 versus p63 or p73 have been reported by in vivo ablation of these genes; p53-, p63-and p73-deficient mice exhibit quite different phenotypes (Donehower et al., 1992; Mills et al., 1999; Yang et al., 1999 Yang et al., , 2000 . p53 family members, especially p73, have been reported to be involved in neuronal and epidermal differentiation (De Laurenzi et al., 2000a, b; Billon et al., 2004) . These differences are likely to depend on activation or repression of different sets of target genes. In this study, we used cDNA microarray to examine 9216 genes in DLD1 human colorectal cancer cells and demonstrated expression of the pigment epithelium-derived factor (PEDF) gene was induced by either p63 or p73, but not by p53. PEDF is a secreted glycoprotein expressed in many tissues (Dawson et al., 1999; Crawford et al., 2001) . Its cell-type-specific functions involve promoting neuronal cell survival (Taniwaki et al., 1995) and acting as a neurotrophin for retinoblastoma cells (Tombran-Tink et al., 1991) . Additionally, PEDF contributes as a natural angiogenesis inhibitor in two hormone-sensitive organs, the prostate and pancreas (Doll et al., 2003) .
To express the human p53 family genes, we generated the replication-deficient recombinant adenoviral vector and named them Ad-p53, Ad-p73a, Ad-p73b, Ad-p63g and Ad-p63a for the p53, p73a, p73b, p63g and p63a genes, respectively (Ishida et al., 2000) . To determine the relative efficiency of adenovirus-mediated gene transfer, several human cancer cell lines were infected with adenovirus containing the bacterial LacZ gene (AdLacZ). They showed highly efficient gene transfer, with 90-100% of the DLD1 and Saos2 cells staining for bgalactosidase activity at an MOI of 50 and 100, respectively (Sasaki et al., 2001) . After infection with Ad-p53, Ad-p73a, Ad-p73b, Ad-p63g and Ad-p63a, exogenous expression of p53, p73a, p73b, p63g and p63a was observed, respectively ( Figure 1a) . We mainly used p73b and p63g isoforms in this study because they activate a p53-responsive reporter gene more strongly than p73a and p63a (Prabhu et al., 1998; Yang et al, 1998; Ishida et al., 2000) . To identify the downstream target genes of p73b and p63g, we used cDNA microarrays to compare the expression level of 9216 known genes in a human colorectal cancer cell line DLD1 infected separately with Ad-p53, Ad-p73b or Adp63g. Briefly, poly(A) þ RNA was extracted from adenovirus-infected cells with the FastTrack 2.0 mRNA isolation system (Invitrogen) and used as a template for synthesis of Cy3-or Cy5-labeled cDNA probes. The probes were hybridized to cDNA microarrays. Microarray construction, hybridization procedure and data analysis were described previously (Ono et al., 2000; Okabe et al., 2001) . We selected several genes whose expression level was altered at least threefold in p73-and p63-infected cells, but not in p53-infected cells (Table 1 and Figure 1b) . One of the genes, PEDF, was specifically induced by p73 and by p63 in DLD1 cells (Figure 1c) . These results were validated by two independent cDNA microarray experiments, and were confirmed by Northern blot analysis. Expression of the PEDF gene was increased in DLD1 cells 12 h after infected with Adp73b or Ad-p63g, but was not significantly increased after infection with Ad-p53 or Ad-LacZ (Figure 1c ). We -12) , respectively, and the cells were harvested 24 h after infection. Immunoblot analysis was performed on lysates (10 mg) from cells infected with Ad-LacZ (lanes 1 and 7), Ad-p53 (lanes 2 and 8), Ad-p73a (lanes 3 and 9), Ad-p73b (lanes 4 and 10), Ad-p63g (lanes 5 and 11) and Ad-p63a (lanes 6 and 12). The primary antibodies used were as follows: mouse anti-human p53 mAb (DO-7; Santa Cruz Biotechnology, top), mouse anti-human p73 mAbs (GC-15 and ER-15; Oncogene Research, second), mouse anti-human p63 mAb (D9; Santa Cruz Biotechnology, third) and mouse anti-human actin mAb (C4; Chemicon, bottom). (b) Venn diagram of genes upregulated by p53, p73b and p63g. Only genes that showed at least three-fold upregulation as compared to the control (LacZ) were included in the analysis. The diagram shows that 12 genes were upregulated by both p73b and p63g but not by p53 (Table 1) . (c) Time course of PEDF mRNA induction after Ad-mediated transfer of p73b and p63g in DLD1 cells. DLD1 cells were infected with Ad-LacZ, Ad-p53, Adp73b or Ad-p63g at an MOI of 50, and the cells were harvested at the indicated time after infection. Total RNA was extracted and 10 mg were subjected to Northern blot analysis with a human PEDF cDNA probe. Ethidium bromide staining of 28S rRNA (28S) in the bottom row shows that equal amounts of RNA were loaded in each lane. (d) Total RNA (10 mg) extracted from SW480, CHC-Y1, A172, H1299, U373, Saos2 and HCT116 cells infected with the indicated adenoviruses for 24 h was fractioned and hybridized with human PEDF (top) and p21 (middle) cDNAs. Hybridization was performed using 32 P-labeled cloned cDNA fragments of PEDF (nucleotides 346-1353) and p21 (nucleotides 11-429) PEDF is a direct target of p63 and p73 Y Sasaki et al examined the expression of the PEDF gene in several human cancer cell lines, including SW480, HCT116, CHC-Y1 (colorectal cancers), A172, U373 (glioblastomas), H1299 (lung cancer) and Saos2 (osteosarcoma). p73b and p63g induced the PEDF gene in SW480, U373, Saos2 and HCT116 cells, whereas PEDF was not significantly induced by p53 in these cell lines (Figure 1d ). In CHC-Y1 cells PEDF was induced only by p73b, whereas in H1299 cells, PEDF was not significantly induced by p53, p73b or p63g. In HCT116 cells, PEDF was induced by p73a more efficiently than by p73b. p53 induced PEDF as efficiently as p73b and p63g only in A172 cells. In contrast, p53 induced p21 significantly in all cell lines we tested ( Figure 1d , middle row). Taken together, the results presented here suggest that the PEDF gene is a specific target of p73 and p63. To determine whether p73 and p63 can bind directly to the regulatory region of the PEDF gene, we searched for a consensus p53-binding sequence in the PEDF gene since it has reported that the p63 and p73 proteins can bind to p53-binding sequences (El-Deiry et al., 1992; Jost et al., 1997; Kaghad et al., 1997; Osada et al., 1998; Yang et al., 1998) . We obtained the genomic sequence of Expression of FLAG-tagged p53, p73, and p63 after adenovirus infection in Soas2 cells (left). Cells were infected with Ads at an MOI of 50 and were harvested 24 h after infection. Immunoblot analysis was performed on lysates (10 mg) from cells infected with Ad-LacZ, Ad-Fp53, Ad-Fp73a, Ad-Fp73b, Ad-Fp63g and Ad-Fp63a. The primary antibodies used were as follows: mouse anti-FLAG epitope mAb (M2; Sigma, top), mouse anti-human actin mAb (C4; Chemicon, bottom). In vivo recruitment of p63 and p73 proteins to RE-PEDF (right). The chromatin immunoprecipitation (ChIP) assay was performed as described previously Sasaki et al., 2002 ) using a ChIP assay kit (Upstate Biotechnology). Crosslinked chromatin was extracted from Saos2 cells after infection with Ad-LacZ, Ad-Fp53, Ad-Fp73a, Ad-Fp73b, Ad-Fp63g and Ad-Fp63a, and then immunoprecipitated with anti-FLAG antibody M2. The immunoprecipitated material was amplified using primers specific for RE-PEDF, the p21 promoter or two other candidate sites (À6362 and À5996). (c) The luciferase reporter assay was performed as described previously (Ishida et al., 2000; Morimoto et al., 2002; Sasaki et al., 2002) . Saos2 cells were transiently transfected with the pGL3-promoter vector (Promega) containing the RE-PEDF (wt: 5 0 -aaacttgttttaaaacaagcttgtgtaacccatgacc-3 0 ) or a mutant sequence (RE-PEDF-mut: 5 0 -aaaatttttttaaaaaaatcttgtgtaaccaattacc-3 0 ) along with phRL-TK (Promega) by using Lipofectamine plus reagent (Invitrogen). Saos2 cells were cotransfected with a control pcDNA3.1 vector or a vector that expresses p53, p73a, p73b, p63g and p63a 24 h prior to performing the luciferase assay. Luciferase activity was measured by means of the dual-luciferase reporter assay system (Promega) with the Renilla luciferase activity as the internal control. Columns indicate the mean luciferase activity levels; bars indicate the s.d. (left). The relative luciferase activity was defined as the ratio of luciferase activity in the cells transfected with the pGL3-RE-PEDF-wt relative to the activity in cells transfected with the mutant reporter plasmid, pGL3-RE-PEDF-mut (right) the human PEDF gene from the GeneBank database (Accession number U29953). We then searched for consensus p53-binding sites within 10 kb in and around the exon 1 of the PEDF gene and found three candidate sequences at the positions À6362, À5996 and À1366, where þ 1 represents the transcription start site (Figure 2a ). Chromatin immunoprecipitation (ChIP) assay was performed to determine whether the p63 and p73 protein could bind to these candidate sequences in vivo. The ChIP assay relies on the ability of specific antibodies to immunoprecipitate DNA-binding proteins along with the associated genomic DNA. For the ChIP assay, we used Saos2 cells infected with Ad-LacZ and Ad-Fp53, Ad-Fp73a, Ad-Fp73b, Ad-Fp63g and AdFp63a expressing FLAG-tagged genes (Figure 2b, left) . Crosslinked chromatin from these cells was immunoprecipitated with an anti-FLAG monoclonal antibody. We then measured the abundance of candidate sequences within the immunoprecipitated complexes by PCR. As shown in Figure 2b , one DNA fragment containing a candidate sequence at (À1366) was reproducibly present in the immunoprecipitated complex containing p73 or p63 protein (Figure 2b, top row) . We designated this sequence RE-PEDF (for responsive element in PEDF), which consists of three copies of the 10-bp consensus p53-binding motif separated by 2 and 5 bp (Figure 2a) . In contrast, we did not detect p53 protein binding to the RE-PEDF sequence in Ad-Fp53-infected cells, as assessed by the ChIP assay and subsequent PCR amplification (Figure 2b, top row) . The other two candidate sequences were amplified in the input chromatin-positive control for PCR but not in the Figure 3 (A) Secreted PEDF protein in condition media. A total of 2 Â 10 6 SW480 cells were infected with Ad-LacZ, Ad-p53, Adp73b or Ad-p63g. After 24 h, media were aspirated, and the cells rinsed twice with serum-free DMEM. Fresh serum-free DMEM was then added and cells were incubated for 24 h, and the media were collected and centrifuged (1000 g, 5 min) to remove debris. The supernatant was used to culture Saos2 cells or was concentrated using Centricon YM-10 (Millipore) for immunoblot analysis. The blot was probed with an anti-PEDF mAb (MAB1059, Chemicon). (B) Phase-contrast microscopy. Saos2 cells cultured for 24 h in the condition media prepared from SW480 cells infected with Ad-LacZ (a, e), Ad-p53 (b, f), Ad-p63g (c, g) or Ad-p73b (d, h). Saos2 cells cultured in the condition media from Ad-p63g-infected and Ad-p73b-infected SW480 cells showed morphological changes characteristic of differentiation (c, d). However, Saos2 cells cultured with the anti-PEDF antibody showed no changes (e-h). Original magnification was Â 100. The quantification of morphological changes is represented by the percent of cells with neurite outgrowth (inset). (C) Semiquantitative RT-PCR was performed to assess Osteopontin mRNA levels. Total RNA was prepared from Saos2 cells incubated in the condition media prepared from SW480 cells infected with Ad-LacZ, Ad-p53, Ad-p73b or Ad-p63g. In all, 1 mg of DNase I-treated total RNA was reverse transcribed and some fraction of the RT reaction was amplified by PCR. The following PCR primers were used: 5 0 -accatgagaattgcagtgatttgc-3 0 and 5 0 -atcagtgaccagttcatcagattc-3 0 for Osteopontin, 5 0 -accacagtccatgccatcac-3 0 and 5 0 -tccaccaccctgttgct gta-3 0 for GAPDH (glyceraldehyde-3 phosphate dehydrogenase). PCR products amplified in limited numbers of PCR cycles were analysed by agarose-gel electrophoresis and ethidium bromide staining. Anti-PEDF antibody was added to CM prepared from Ad-p73b-infected cells to neutralize PEDF(p73 þ Ab). Expression of the GAPDH gene was examined as a quality control Quantitative changes in gene expression in DLD1 cells infected with Ad-p73b and Ad-p63g compared with Ad-LacZ control immunoprecipitates with the anti-FLAG antibody (À6362 and À5996 in Figure 2b , third and bottom rows). As expected, p53, p73 and p63 proteins resided at the p21 promoter in vivo (Figure 2b , second row). Thus, these results indicated that both p73 and p63 proteins can bind specifically to RE-PEDF in Saos2 cells in vivo.
To determine whether p73 and p63 can transactivate gene expression via RE-PEDF, we performed a heterologous promoter-reporter assay using a luciferase vector that contains RE-PEDF sequence upstream of the basal SV40 promoter and a control reporter plasmid containing a mutated RE-PEDF sequence. Transient transfection of these constructs into Saos2 cells followed by a luciferase reporter assay revealed that transcriptional activity could be increased via RE-PEDF by p73 or p63 but not by p53 (Figure 2c ). These results are consistent with the induction of endogenous PEDF by p73 and p63. Furthermore, an approximately 50 kDa protein was detected by immunoblotting with antibodies against PEDF-derived peptides in conditioned media (CM) prepared from SW480 cells infected with Ad-p73b or Ad-p63g ( Figure 3A ), suggesting that exogenous p73 and p63 induce secreted PEDF protein in SW480 cells. p53 family members, especially p73, are involved in neuronal or epidermal differentiation. We therefore tested whether PEDF expression mediated by p73 or p63 could induce cellular differentiation. When Saos2 cells were maintained in CM prepared from SW480 cells 48 h after infection with Ad-p73b or Ad-p63g, Saos2 cells showed morphological changes characteristic of differentiation ( Figure 3B,c and d) . There was an increase in the number of cells with neurites and an increase in neurite length. On the other hand, there were no cells with increased neurite length when anti-PEDF antibody was added ( Figure 3B,g and h) . To clarify whether these morphological changes demonstrate differentiation, we performed semiquantitative RT-PCR to assess Osteopontin mRNA levels, a typical osteoblast differentiation marker ( Figure 3C ). These results suggest that p63 and p73 induce cell differentiation mediated in part by PEDF.
In this study, it is revealed that PEDF expression is preferentially induced by p63 and p73. We identified a specific response element for p63 and p73 1366-bp upstream of the PEDF gene assessed by a ChIP assay and a heterologous promoter assay. Nearly all p53 response elements reported previously contain two adjacent copies of the 10-bp p53-binding motif, whereas studies in our laboratory and in others of response elements for p73 and p63 show that these elements preferentially consist of three or more copies of the 10-bp consensus p53-binding motif separated by spacer sequences (Zheng and Chen, 2001; Sasaki et al., 2002 Sasaki et al., , 2003 . Based on these observations, we conclude that PEDF expression is directly controlled by p63 and p73.
PEDF has been originally isolated from the CM of human retinal pigment epithelial cells as a factor that induced neuronal differentiation of retinoblastoma cells (Tombran-Tink et al., 1991) . PEDF is also known to be a noninhibitory serpin because its sequence and structural homology to the serine protease inhibitor (serpin) family and because it does not inhibit proteases . PEDF is involved in differentiation and cell survival, and has antiangiogenesis activity. PEDF was also shown to induce neuronal differentiation of a neuroblastoma cell line and has a neurotrophic survival effect on cerebellar granule cells (Taniwaki et al., 1995) . Additionally, PEDF was reported to be a potent inhibitor of angiogenesis in the eye (Dawson et al., 1999) . Since angiogenesis is required for some tumors to grow, invade and metastasize (Holmgren et al., 1995; Carmeliet and Jain, 2000) , targeting vasculatures that support tumor growth is considered a promising approach to cancer therapy.
It is well known that PEDF induces apoptosis in endothelial cells and epithelial cells when it is added exogenously Doll et al., 2003) . On the other hand, it is known that p63 and p73 induce cell cycle arrest and apoptosis (Sasaki et al., 2001; Dietz et al., 2002) . It was also reported that human colorectal cancer cell lines that were resistant to p53-mediated apoptosis underwent apoptosis after transduction of p63g or p73b (Sasaki et al., 2001) . Our results of differential gene activation by particular p53 family members may help explain this difference.
Here, we demonstrated a physical as well as a functional involvement of p63 and p73 in differentiation of an osteosarcoma cell line. Both p63 and p73 can transactivate the promoters of genes associated with neuronal or epidermal differentiation and induce expression of markers of differentiation. In conclusion, we report here that p63 and p73 but not p53 induce PEDF expression through a direct binding site of the PEDF gene and can induce cellular differentiation.
